Table 1:
Main population, neonatal, and delivery characteristics (n = 26)a
| Characteristics | |
|---|---|
| Pregnancy and maternal | |
| Maternal age (yr) | 32.5 (21–42) |
| In vitro fertilization | 3/26 (11.5%) |
| Multiple pregnancies | 2/26 (7.7%) |
| Maternal infection | 5/26 (19.2%) |
| CMV | 4/26 (15.3%) |
| Toxoplasma | 1/26 (3.8%) |
| Maternal medical treatment | 5/26 (19.2%) |
| Maternal hypercoagulative disorder | 4/26 (15.3%) |
| TOP | 6/26 (23.1%) |
| Fetal and neonatal | |
| Male/female ratio (15:11) | 1.4:1 |
| Fetal abnormalities | |
| IUGR | 4/26 (15.4%) |
| CMV infection | 2/26 (7.7%) |
| Chromosomal aberration | 2/26 (7.7%) |
| Abnormal fetal echocardiogram findings | 1/26 (3.8%) |
| GA at MRI diagnosis (wk) | 33 (29–38) |
| Birth GA (wk) | 38 (35–41) |
| BW (g) | 3210 (2445–4060) |
| Apgar score | |
| At 1 min | 9 (8–9) |
| At 5 min | 10 (8–10) |
| Mode of delivery (n = 20) | |
| Vaginal delivery | 11/20 (55%) |
| Cesarean delivery | 7/20 (35%) |
| Assisted vaginal delivery | 2/20 (10%) |
Note:—GA indicates gestational age, BW, birth weight.
a
Data are expressed as median (range) or number (percentage).